| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.22 |
4e-05 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0002 |
| mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
0.001 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.001 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |